Avantax Planning Partners Inc. Has $457,000 Position in Colgate-Palmolive (NYSE:CL)

Avantax Planning Partners Inc. decreased its position in Colgate-Palmolive (NYSE:CL) by 6.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,029 shares of the company’s stock after selling 364 shares during the period. Avantax Planning Partners Inc.’s holdings in Colgate-Palmolive were worth $457,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive in the 4th quarter valued at $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive in the 4th quarter valued at $32,000. Finally, OFI Invest Asset Management acquired a new position in Colgate-Palmolive in the 4th quarter valued at $36,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 3.5 %

Shares of NYSE CL opened at $94.05 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $76.32 billion, a price-to-earnings ratio of 26.72, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The firm has a 50-day moving average price of $89.03 and a 200 day moving average price of $94.99. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the company earned $0.87 earnings per share. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CL shares. Morgan Stanley lowered their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, March 3rd. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Stifel Nicolaus dropped their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Finally, JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.